Weekly Report on Healthcare Industry | Yangqi Medical Chip Secures Tens of Millions in Pre-A Funding; Youth Anxiety Fuels Glucose Monitor Boom

In recent years, innovation in the healthcare and health industry has been emerging constantly, developing into one of the most dynamic industries. 36Kr has witnessed and accompanied the growth of innovative companies in this field, bringing a professional voice to the industry.

To this end, 36Kr has launched the column "Healthcare Industry Weekly Report," which will be released regularly in the future to provide readers with industry information from multiple perspectives, including capital, policy, finance, new products, and more.

Please check the healthcare industry weekly report for November 24th. This weekly report includes financing news in the healthcare field this week.

Financing and Investment

• Precision Radiotherapy Company "Yangqi Medical" Secures Tens of Millions in Pre-A Round Financing

Recently, the precision nuclear medical enterprise "Yangqi Medical" has completed a Pre-A round of financing worth tens of millions of yuan. This round of financing was led by Anfeng Venture Capital, and the funds raised will be mainly used for marketing of approved products, R&D and approval of new products, and expansion into the pet radiotherapy market. Yangqi Medical, established in 2021, focuses on the development of nuclear medical and tumor radiotherapy products. The company's founding team is composed of experts from Stanford, Alibaba, and other leading institutions in the fields of nuclear medicine, nuclear physics, and artificial intelligence both in China and abroad. For a long time, radiotherapy has faced issues such as rough treatment planning during procedures, insufficient precision during the process, and overly long treatment durations. To address these challenges, Yangqi Medical empowers precise radiotherapy through its self-developed optical navigation technology. The company’s current product portfolio includes the optical surface monitoring product "Qishi," the low-dose CT enhancement product "Qingying," and SRT low-energy superficial radiotherapy equipment.

Precision Radiotherapy Company "Yangqi Medical" Secures Tens of Millions in Pre-A Round Financing, Core Product to Obtain Certification Within the Year | 36Kr Exclusive

• BVLASER Completes Tens of Millions of Yuan in B+ Round Financing

BVLASER Announces Completion of Tens of Millions of Yuan in B+ Round Financing, Exclusively Invested by Mifang Health FundBVLASER, a company dedicated to the research, production, and sales of mid-to-high-end medical aesthetic photonic devices, has announced the completion of tens of millions of yuan in B+ round financing. This round was exclusively invested by Mifang Health Fund. The funds will primarily be used for expanding production capacity, further developing global markets, enhancing brand image, and innovating and iterating self-developed products. The company owns more than 10 core products and over 100 intellectual property certificates, and is also a national-level high-tech enterprise. Currently, its products have been exported to more than 70 countries and regions, with business performance achieving over 100% growth compared to 2023.

• TGI Completes Pre-A+ Round Financing Worth Tens of Millions of RMB

Hefei TG ImmunoPharma Co., Ltd. Announces Completion of Tens of Millions of Yuan in Pre-A+ Financing RoundHefei TG ImmunoPharma Co., Ltd. announced the completion of a pre-A+ financing round worth tens of millions of yuan. This round of financing was led by Hefei Industrial Investment Management, with participation from multiple investment institutions including Zhongke Chuangxing, Keda Silicon Valley, and Haiyuan Capital. The proceeds from this round will provide significant financial support for TGI’s product development, advancing clinical trials of core products and the development of new products, while accelerating the clinical translation of innovative immunotherapeutic drugs. TGI is a biotech company founded by a research team led by Professor Tian Zhigang, an academician of both the Chinese Academy of Engineering and the European Academy of Sciences. The company is committed to the development of innovative target immunotherapeutic drugs. With over 30 years of focus on anti-tumor immunity research, the team has spent the last decade utilizing the principles of the body's natural anti-cancer immunity to discover new targets for cancer immunotherapy drugs and develop antibody-based immunotherapeutics.

• ShenNa Tech Completes Financing Worth Tens of Millions of Yuan

Shengna Technology (Shanghai) Co., Ltd. Completes Pre-A Round Financing, Raising Tens of Millions of YuanShengna Technology (Shanghai) Co., Ltd. has completed its Pre-A round of financing, with the total amount reaching tens of millions of yuan. It is reported that this round of financing was led by Fir Creek Capital. The raised funds will be used for the clinical trial research application of the company’s small-diameter artificial blood vessel products and to accelerate the clinical translation of the company’s globally leading biomicronanotechnology. Shengna Technology was founded in 2015 by Professor Song Li, an expert in biomedical materials and former chair of the Department of Bioengineering at the University of California, Los Angeles (UCLA), together with Dr. Weimin Dai, president of the Berkeley Shanghai Alumni Association, with support from the Zhangjiang Berkeley Innovation Center. The company focuses on the development and application of biomicronanotechnology in high-value medical devices and new materials fields. The company has established a leading platform for the application and clinical translation of biomicronanotechnology and developed a series of products based on biomicro-nano materials.

• Baimingxin Kang Completes New Round of Financing Worth Hundreds of Millions

Bioming Biopharma, a biopharmaceutical company focused on providing breakthrough immunotherapy solutions, announced the completion of a new round of financing worth hundreds of millions of yuan. This round of financing was jointly invested by several well-known institutions and industry investors, including PICC Capital Equity, Clearpine Capital, and a renowned industrial investment institution. Founded in 2018, Bioming Biopharma is committed to developing next-generation specific immunotherapy for allergic and autoimmune diseases. The company owns a wholly-owned subsidiary in Europe that integrates production, research, and sales, with dozens of commercialized products. The company is actively expanding into global markets and promoting the clinical development and commercialization in China of innovative allergy immunotherapy products already on the market in Europe.

Med氪

• Young People's Anxiety Is Driving the "Big Business" of Blood Glucose Meters | Yikr

First of all, this is not for the purpose of treating diseases, An Yu wants to emphasize this point.

Her blood sugar control experiment began at a small health salon. The presenter said, "Don't take your health for granted," and then went on to explain in detail the effects of blood sugar imbalance on the body, such as fatigue, sugar cravings, weight gain, and hormonal disorders. An Yu has an obsessive pursuit of "efficiency" and "optimization." If her work performance is affected by the drowsiness caused by a post-meal blood sugar spike, or if stress leads to binge-eating impulses, she "really can't tolerate it."

As a result, purchasing a blood glucose meter to monitor the impact of food intake on blood sugar became the simplest way to maintain mental well-being. After being "controlled" by the numbers on an app for a few weeks, An Yu successfully quit coffee and ice cream, developed a love for drinking plain water, and felt "more focused during the day."

On Xiaohongshu, posts sharing experiences of managing blood sugar with continuous glucose monitors and weight loss journeys are the real "traffic code." Among the hundreds of comments, netizens enthusiastically discuss whether carrots or oat milk are the "blood sugar killers," how to eat fruits to minimize sugar intake, and how many units their blood sugar increased after eating certain foods...Click here for more details）

Editor: Hu Xiangyun